Article citationsMore>>

Arnett, M.K., Macintosh, E.M., James, S.E., Nathan, M.A., Shen, K.R., Ravi, K., Neben Wittich, M.A., Haddock, M.G. and Hallemeier, C.L. (2017) Utility of (18)F-FDG PET for Predicting Histopathologic Response in Esophageal Carcinoma Following Chemoradiation. Journal of Thoracic Oncology, 12, 121-128.
https://doi.org/10.1016/j.jtho.2016.08.136

has been cited by the following article:

• TITLE: Percentage Change on FDG-PET/CT Predicts Complete Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer

  AUTHORS: Esther Jimenez-Jimenez, Irene Ortiz, Neus Aymar, Raquel Roncero, Pedro Mateos, Marta Gimenez, Jose Pardo, Sebastià Sabater

  KEYWORDS: PET/CT, Esophageal, Response, SUV, Percentage

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.10 No.10, October 22, 2019

  ABSTRACT: Objective: We evaluated whether the changes in FDG-PET/CT uptake between pre/and post-treatment might predict a complete response in esophageal cancer (EC). Patients and Methods: Fifty-six patients with 2 PET-CTs studies were evaluated retrospectively. Images were evaluated qualitatively and semiquantitatively (SUVs). Patients were classified as persistence of disease, complete metabolic response and unspecific FDG uptake. The SUVmax values and percentages of change in SUV were measured. Results: A significant difference was found between the persistence group and the non-persistence group regarding the median percentage change in SUVtumor (72.95% vs. 54.12%; p = 0.04) and regarding the percentage change in SUVnode (89.91% vs. 59.91%, p = 0.04). In patients treated with radiochemotherapy (RCTX), a significant difference was found between the persistence group and the no persistence group regarding the percentage change in SUVtumor (58.02% vs. 78.59%). Overall survival rate was related to the percentage of change in the SUVtumor. The group of ≥75% of change SUVtumor showed a median survival of 37.32 months (IC: 95% = 49.93 - 24.70) and the group of